Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Immunology and Cell Biology
|
March 13, 2003
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator
Nikolai Petrovsky, Luis Socha, Diego Silva, et al.
Cancer Research
|
October 18, 2002
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers
Toshiya Atsumi, Jason Chesney, Christine Metz, et al.
Archives of Physical Medicine and Rehabilitation
|
April 27, 2013
Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury
Adam Stein, Arti Panjwani, Cristina Sison, et al.
Archiv Der Pharmazie
|
November 19, 2013
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor
Mingzhu He, Christine Metz, Kai Fan Cheng, et al.
Journal of Neuroimmunology
|
September 21, 2005
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis
Ferdinando Nicoletti, Alain Créange, David Orlikowski, et al.
Diabetes Care
|
May 29, 2002
Advanced glycation end products and endothelial dysfunction in type 2 diabetes
Kathryn C B Tan, Wing-Sun Chow, Victor H G Ai, et al.
The Journal of Biological Chemistry
|
October 30, 2016
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential
Joshua Bloom, Christine Metz, Saisha Nalawade, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 24, 2002
A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients
Jianming Wu, Christine Metz, Xiulong Xu, et al.
Nature Medicine
|
October 27, 2004
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Hong Wang, Hong Liao, Mahendar Ochani, et al.
Journal of Cellular Physiology
|
December 8, 2007
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
Stanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Immunology and Cell Biology
|
March 13, 2003
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator
Nikolai Petrovsky, Luis Socha, Diego Silva, et al.
Cancer Research
|
October 18, 2002
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers
Toshiya Atsumi, Jason Chesney, Christine Metz, et al.
Archives of Physical Medicine and Rehabilitation
|
April 27, 2013
Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury
Adam Stein, Arti Panjwani, Cristina Sison, et al.
Archiv Der Pharmazie
|
November 19, 2013
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor
Mingzhu He, Christine Metz, Kai Fan Cheng, et al.
Journal of Neuroimmunology
|
September 21, 2005
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis
Ferdinando Nicoletti, Alain Créange, David Orlikowski, et al.
Diabetes Care
|
May 29, 2002
Advanced glycation end products and endothelial dysfunction in type 2 diabetes
Kathryn C B Tan, Wing-Sun Chow, Victor H G Ai, et al.
The Journal of Biological Chemistry
|
October 30, 2016
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential
Joshua Bloom, Christine Metz, Saisha Nalawade, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 24, 2002
A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients
Jianming Wu, Christine Metz, Xiulong Xu, et al.
Nature Medicine
|
October 27, 2004
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Hong Wang, Hong Liao, Mahendar Ochani, et al.
Journal of Cellular Physiology
|
December 8, 2007
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
Stanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, et al.
Page
of 3